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Background: Level I evidence shows conventional carotid endarterectomy (CEA) with patch angioplasty results in lower
rates of restenosis. However, whether this information has affected practice patterns and outcomes in real-world vascular
surgery settings is unclear.
Methods: Within the Vascular Study Group of New England (VSGNE), we studied 2981 patients undergoing 2981
first-time CEAs between January 1, 2003, and June 31, 2008. Rates of restenosis (defined by duplex ultrasound imaging
at the 1-year follow-up) were estimated using life-table analysis. Cox proportional hazards models were used to identify
multivariable predictors of postoperative restenosis <1 year.
Results: Across 58 surgeons and 11 hospitals, we studied 2611 conventional CEAs (88% of all CEAs) and 370 eversion
CEAs (12% of all CEAs). Median follow-up was 12.8 months (range, 1-35 months). The proportion of conventional
CEAs performed with patching increased from 87% to 96% (P < .001) between 2003 and 2008, whereas eversion CEA
declined from 18% to 5% (P < .001). Restenosis occurred in 303 patients (10%); by life-table analysis, the restenosis rate
at 1 year was 6.2% (95% confidence interval [CI], 4.7%-6.8%). Restenoses were most commonly noncritical: 50%-79%
restenosis in 7.9%, 80%-99% restenosis in 1.7%, and occlusion in 0.5%. Univariate analyses showed significant differences
in 80% to 100% restenosis by procedure type (2% in conventional CEA, 6% in eversion CEA, P < .002), the year of
procedure (3.2% in 2003, 0% in 2008; P< .03), and use of patching in conventional CEA (2.9% no patch, 1% with patch;
P< .008). Bymultivariable analysis, absence of patching (hazard ratio [HR], 3.2; 95%CI, 1.5-7.0), contralateral internal
carotid artery stenosis >80% (HR, 4.1; 95% CI, 1.4-11.5), and dialysis dependence (HR, 3.5; 95% CI, 1.2-9.8) were
independently associated with a higher risk of an 80% to 100% restenosis. Of the 51 patients with 80% to 99% restenosis,
14 underwent reintervention <1 year, comprising 4 reoperations and 10 carotid artery stent procedures. Of the 15
patients with a carotid occlusion <1 year, transient ischemic attacks occurred in 2 and a disabling stroke in 1.
Conclusions: In our region, restenosis after CEA, especially clinically significant restenosis<1 year after surgery, decreased
slightly over time. This improvement in outcome was associated with several factors, including an increase in patching
after conventional CEA, a process of care that was studied and encouraged within our vascular study group. These results
highlight the utility of regional quality-improvement efforts in improving outcomes in vascular surgery. (J Vasc Surg
2010;52:897-905.)Carotid endarterectomy (CEA) remains the standard of
care for the treatment of cervical cerebrovascular disease in
appropriately selected patients, and nearly 100,000 CEAs
are performed annually in the United States.1 CEA, how-
ever, can be complicated by restenosis in the first year
after CEA due to intimal hyperplasia or later due to
progression of underlying atherosclerotic disease. Surgi-
cal techniques such as patch angioplasty after conven-
tional CEA have been studied extensively and have been
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doi:10.1016/j.jvs.2010.05.005shown by level I evidence to decrease the incidence of
restenosis after CEA.2-7
Despite such convincing evidence, surgeons may be
unwilling to adopt patch angioplasty into their routine
practice of conventional CEA.8 First, they may be reticent
to change practice patterns based on traditions gleaned
from their surgical training. Second, they may be unenthu-
siastic about instituting a new process of care based on their
perception of their own results. Restenosis occurs relatively
uncommonly regardless of technique, and the notion that
“my restenosis rate is low already” may be used to justify an
individual surgeon’s decision to forgo routine patching
when performing conventional CEA. Therefore, it is un-
known how widely patch angioplasty is used in real-world
vascular surgery practice.9
In 2003, the Vascular Study Group of New England
(VSGNE), a regional quality-improvement initiative, iden-
tified patching after conventional CEA as a quality measure
that would be reported back to surgeons. Although no
specific quality-improvement project was focused on this
measure, we hypothesized that feedback on this process of
care might change practice patterns. The VSGNE, which
has studied the 1-year outcomes of 3000 CEAs per-
formed in 11 centers between 2003 and 2008, is ideally
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tains extensive clinical detail on practice patterns and pro-
cesses of care used in CEA and also contains a large sample
of CEAs performed in community and academic practice.
METHODS
The Institutional Review Board at Dartmouth Medical
School reviewed and approved our study protocol.
Data were prospectively collected by 58 surgeons and
associated staff in 11 VSGNE hospitals (Appendix A, online
only). This analysis focused on isolated primary CEA and
thus excluded patients who underwent CEA combined
with coronary artery bypass grafting and those undergoing
redo CEA. Hospital data were collected for each patient
and periodically audited against claims data to ensure entry
of all patients. Follow-up data were collected at the time of
the subsequent outpatient evaluation, with data from the
visit closest to 1 year after surgery entered into the database.
Further details on this database have been published previ-
ously,10 and other details are available at www.vsgne.org.
Patients. Between January 1, 2003, and June 31,
2008, 4282 patients underwent 4407 primary CEAs in
Northern New England at the 11 centers participating in
our registry and survived 1 year postoperatively. Follow-up
duplex ultrasound (DU) data were not available for 805
CEAs (18%), and they were excluded from the analysis.
Also excluded were patients who died before long-term
follow-up, and therefore had no DU data available at
follow-up, comprising 20 deaths (0.4%) before discharge
and 155 (3%) before the 1-year follow-up. In 446 patients
who underwent bilateral CEAs (9% of the total), we ana-
lyzed only the first CEA performed per patient to avoid
possible confounding from within-patient dependency,
This left 2981 CEAs in 2981 patients as our cohort for
analysis. The median follow-up time was 12.8 months
(standard deviation, 5.2 months; range, 1-35 months).
Definitions. Our unit of analysis was the operation.
Patients were evaluated for pre-existingmedical comorbidi-
ties, and these data were prospectively entered into our
registry by specifically trained surgeons, nurses, or clinical
data abstractors. More than 70 clinical and demographic
variables were collected on each patient.10,11 Demographic
data and the incidence of patient-level comorbidities are
outlined in Table I and Appendix B (online only). Each
CEA was categorized as conventional or eversion. Primary
vs patch closure of the endarterectomy was recorded, as was
the type of material used for patching, including autoge-
nous vein, polyester (Dacron), bovine pericardium, or
polytetrafluoroethylene. Alsomeasured were other descrip-
tions of operative technique, such as anesthesia type, shunt
use, anticoagulant use, and completion study.
Outcome measures. Our main outcome measure was
the occurrence of any restenosis detected at a follow-up
visit. Restenosis was categorized as none (50%), 50% to
79%, 80% to 99%, or 100% (ie, an occlusion) on postoper-
ative DU examination. Each center determined its ownDU
criteria for each individual threshold, which were constant
over the time period studied. Overall, the restenosis ratewas calculated by dividing the total number of restenosis
events (of any severity) by the total number of CEAs.
Further, for 1-year estimates, we used life-table analysis to
calculate restenosis rates at 1 year, because restenosis status
was assessed at varying lengths of follow-up (range, 1-35
months). These life tables take into account the differences
in follow-up duration and provide the most accurate esti-
mate of restenosis rate at 1 year.
In univariate analyses, we examined the occurrence of
restenosis using several categories of severity (50%-79%,
80%-99%, and 100%). These changes were examined over
time using risk ratios and surrounding 95% confidence
intervals, comparing the first and last years in our study. We
used nonparametric tests of trends to examine the signifi-
cance of changes during the entire study period as well, but
for display purposes used the first and last years of the study
to calculate risk ratios, as we have done in previous
work.12-14 The P values used to represent the comparisons
across multiple groups of years were corrected for multiple
comparisons using the Bonferroni correction.
We also studied the incidence of postoperative stroke,
both in-hospital and at the 1-year follow-up (using life-
table analyses), and considered both ipsilateral and con-
tralateral neurologic events, using methods described pre-
viously.11 A current version of the Social Security Death
Index as well as 1-year follow-up data obtained as part of
VSGNE were used to confirm the survival status of all
patients during the first year after surgery.
To study potential differences in restenosis events
across hospitals, we studied rates of restenosis aggregated
by center. Across hospitals, the total volume of CEAs
during the study period ranged from 6 to 993 CEAs. In our
preliminary power calculations, we determined that a cen-
ter must have entered at least 175 patients into the data set
to allow an 80% likelihood of detecting a difference in
restenosis rate across the range observed in our study (1% to
8%). Therefore, we excluded four centers from center-
specific analyses because they enrolled175 patients at the
time of the analysis. Of import, although center-specific
univariate rates are reported in Table I, the results of no
specific center or surgeon were significantly predictive of
restenosis in our final multivariable model. For similar
reasons, surgeon-specific results were not individually con-
sidered in our analysis, because power calculations indi-
cated that 10 of the 58 surgeons in our data set would
have contributed enough cases to have sufficient power to
eliminate type I or type II error.
Development of a model to predict restenosis.
Although our primary outcome was restenosis (calculated
using time-to-event analyses as described in our life-table
analyses), we also studied univariate comparisons of patient
characteristics with restenosis for patients undergoing con-
ventional or eversion CEA. The latter two categories (80%
to 99% and 100%) were combined for the purpose of
multivariable modeling because these events represent
those with the most clinical interest to surgeons.
Tests of significance were established with log-rank
testing. Risk factors found by univariate analysis to be
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able Cox proportional hazards model to estimate hazard
ratios (HR) and 95% confidence intervals (CI) for resteno-
sis after surgery. Cox-Snell residuals were used to estimate
the predicted risk for restenosis at 1 year, based on each
patient’s risk profile. Given that patch angioplasty affected
Table I. Patient characteristics and 80% to 100% restenosi
Variable
Conventional endartere
% of
total
80%-100% resten
If variable
absent
I
Patient characteristics
Age
40 years 0 . . .
40-49 3 . . .
50-59 14 . . .
60-69 32 . . .
70-79 40 . . .
80-89 12 . . .
90 0 . . .
Male gender 60 1.7
Right side 49 1.5
Nonwhite race 1 1.6
Urgency
Elective 85 . . .
Urgent 14 . . .
Emergent 1 . . .
Smoking, prior or current 79 1.1
Diabetes 29 1.6
Creatinine 1.8% 5 1.5
Hypertension 86 1.8
-blockers 83 2.0
Coronary disease 34 1.7
Prior CABG or PCI 33 1.6
Congestive heart failure 7 1.7
Ipsilateral degree of stenosis
50% 1 . . .
50% 2 . . .
60% 5 . . .
70% 19 . . .
80% 73 . . .
Occluded 1% . . .
Dialysis 1 1.5
Contralateral degree of stenosis
50% 59 . . .
50% 10 . . .
60% 8 . . .
70% 7 . . .
80% 6 . . .
Occluded 6 . . .
Center-specific ratesa (vol 175)
Center 1 . . . . . .
Center 2 . . . . . .
Center 3 . . . . . .
Center 4 . . . . . .
Center 5 . . . . . .
Center 6 . . . . . .
Operative characteristics
Shunting for neurologic changes 6 1.8
Patch angioplasty 91 4.2
Protamine 51 2.5
aCombined results for both conventional and eversion procedures.only conventional CEA, a distinct model was created spe-cifically for conventional CEA, and a separate model was
created for eversion CEA. Backwards stepwise regression
was used to construct the models using the variables de-
scribed above. Model discrimination was then evaluated by
concordance testing.15,16 Further, to ensure the model
performed well across risk strata, we compared restenosis
e in univariate analysis
y (n  2611) Eversion endarterectomy (n  370)
te, %
P
% of
total
80%-100% restenosis rate, %
P
iable
nt
If variable
absent
If variable
present
0 . . . 0 . . . . . . . . .
6 . . . 2 . . . 0.0 . . .
8 . . . 13 . . . 16.0 . . .
0 . . . 32 . . . 10.4 . . .
7 . . . 41 . . . 3.1 . . .
1 . . . 13 . . . 6.3 . . .
0 .001 1 . . . 33.0 .012
5 .477 57 7.5 7.7 .472
7 .148 44 5.6 9.2 .184
0 .954 0 7.6 . . . . . .
5 . . . 97 . . .. 7.9 . . .
5 . . . 4 . . . 4.1 . . .
0 .493 0 . . . . . . .511
8 .737 76 8.7 7.3 .839
3 .482 30 7.2 8.6 .65
5 .987 6 8.2 4.7 .567
6 .924 89 11.1 7.2 .347
5 .548 89 6.7 7.8 .795
5 .797 29 7.2 8.6 .627
4 .534 28 6.7 10.0 .266
5 .227 7 7.9 3.3 .427
0 . . . 1 . . . 25.0 . . .
0 . . . 1 . . . 0.0 . . .
8 . . . 3 . . . 0.0 . . .
7 . . . 24 . . . 2.1 . . .
9 . . . 70 . . . 9.4 . . .
0 .483 1 . . . 0.0 .117
.05 1 7.6 0.0 .774
4 . . . 47 . . . 3.2 . . .
3 . . . 5 . . . 14.2 . . .
3 . . . 8 . . . 9.7 . . .
5 . . . 21 . . . 8.4 . . .
52 . . . 6 . . . 16.0 . . .
4 .004 6 . . . 3.3 .006
3 . . . . . . . . . . . . . . .
6 . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
. . . . . . . . . . . . . . .
2 .0001 . . . . . . . . . . . .
. . . . . .
6 .012 6 7.4 6.7 .303
4 .001 8 8.0 3.2 .337
8 .0001 17 8.9 1.5 .038s rat
ctom
osis ra
f var
prese
100.
4.
1.
1.
1.
1.
0.
1.
1.
0.
1.
2.
0.
1.
1.
1.
1.
1.
1.
1.
0.
0.
0.
0.
0.
1.
0.
11
1.
1.
1.
2.
4.
3.
5.
1.
1
1
1
1.
3.
1.
0.using our model across differing groups of patient risk. The
003.
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rank tests. All models were derived using data from 2003 to
2007 (93% of the total), and validation analyses were
performed using data from 6 months in 2008 (7% of the
total). All analyses were performed using Excel (Microsoft,
Redmond, WA) and STATA software (StataCorp, College
Station, Tex).
RESULTS
Patient characteristics. Patients were most com-
monly male (59%), with a mean age of 73 years, and 99%
were white (Table I). Nearly all patients were prior or
current smokers (79%), 30% had a history of diabetes, 34%
had coronary disease, and 23% had a history of chronic
obstructive pulmonary disease. In terms of symptom status,
52% of patients were symptomatic (38% ipsilateral, 13%
contralateral or non-specific), and 48% were asymptomatic.
Further details about the characteristics of the cohort used
are available in Table I and Appendix B (online only).
Operative details, stroke, and death. Operative de-
tails are described in Table I. Conventional CEA was per-
formed in 87% of patients and eversion CEA in 13%. The
proportion of patients who underwent eversion CEA de-
creased significantly over time, from 18% of all cases in
2003 to only 5% in 2008 (P .0001). Regional anesthesia
was used in 11% of CEAs. Shunts were used routinely in
45% of CEAs, and heparin was reversed with protamine in
48%. A completion study was obtained in 33% of CEAs,
with a Doppler probe (63%), a DU examination (33%), or
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Fig 1. Trends in the incidence of restenosis after carot
restenosis rate in 2008 relative to the restenosis rate in 2angiography (2%).The overall incidence of stroke or death after CEA was
1.2% at discharge (42 deaths, 24 stroke-related). One ad-
ditional patient died of stroke within30 days. The overall
incidence of stoke or death1 year after CEAwas 2.4% (61
strokes, 60 deaths, 26 of which were stroke-related). There
was a trend for reduction in the incidence of stroke or death
1 year after CEA during the study period, from 2.5% in
2003 to 1.4% in 2007, but this change was not significant
(P  .682).
Restenosis rate after CEA. The overall occurrence of
any restenosis (50%) after CEA was 10% (303 of 2981
procedures). Restenosis was noncritical in nature in most
patients: 7.9% had a 50% to 79% restenosis, 1.7% had an
SGNE 2003-2008
0%
0.7%
.2%
.4%
0.0%
6.1%5.7%
.1%
0.9%
0.2%
7.0%6.6%
06 2007 2008
Restenosis 100%
RR 1.09 
(95% CI 0.76-1.41) 
 Restenosis 50-80%
RR 0.84 
(95% CI 0.70-0.98)
Restenosis 80-99%
RR 0.22
(95% CI 0.05-0.39) 
 Any Restenosis
RR 0.63 
(95% CI 0.50-0.76)
arterectomy. The risk ratio (RR) was calculated as the
CI, Confidence interval.
Table II. Univariate association of extent of restenosis
with use of patching in conventional endarterectomy
Variable Patch angioplasty
No patch
angioplasty P
Extent of restenosis
All restenosis 7.9 20.0 .0001
50%-79%
restenosis 6.6 14.1 .0001
80-99% restenosis 1.0 5.0 .0001
Occlusion 0.4 0.9 .12
Follow-up (mon),
median (95%
CI) 32.5 (31.2-33.4) 31.4 (29.5-32.4) .421
CI, Confidence interval.1
n V
2.
10
13
1
20
r
id end80% to 99% restenosis, and 0.5% had 100% restenosis
used.
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99% restenosis were asymptomatic in most cases, but 3 of
288 (approximately 1%) sustained a stroke. Of the 51
patients with 80% to 99% restenosis, reintervention was
performed 1 year in 14 (27%), consisting of 4 reopera-
tions and 10 carotid artery stent procedures. Of the 15
patients with a carotid occlusion 1 year, transient isch-
emic attacks occurred in 2 and disabling stroke in 1. The
incidence of reintervention 1 year after CEA did not
change appreciably over time (1.0% in 2003, 0.5% in 2008, P
 .315). One reoperative CEA resulted in stroke, but none of
the angioplasty/stent procedures were complicated by stroke.
Because postoperative follow-updidnot always occur at 1 year
(mean follow-up, 12.8 months), we used life-table analysis to
calculate the 1-year restenosis rate, which was 6.2% (95% CI,
4.7%-6.8%) for any stenosis 50% and 1.5% (95% CI, 0.7%-
2.0%) for 80% to 99% stenosis.
Several univariate associations between patient and
procedural variables were identified (Table I). In particular,
the risk of restenosis, as well as the extent of restenosis, was
significantly associated with three distinct factors: the year
of procedure, the use of patch angioplasty, and the tech-
nique of endarterectomy.
First, the overall restenosis rate declined slightly during
the study period, from 11% in 2003 to 7% in 2007 (risk
ratio, 0.63; 95% CI, 0.50-0.76, P .04; Fig 1). The extent
of restenosis also varied by year during the study period; for
example, the rate of 50% to 79% stenosis decreased by 16%
(P .01), and the rate of 80% to 99% stenosis decreased by
78% (P  .01). The rate of carotid occlusion, however,
remained stable at approximately 1% per year (Fig 1).
Second, use of patch angioplasty after conventional
Fig 2. Rate of patching and type of patch material used
shown by year. *Note that the black line above the g
proportion of polytetrafluoroethylene patches that wereCEA was associated with significantly lower rates of reste-nosis (Table II). This association was similar, irrespective of
the extent of restenosis. Especially in patients with 50% to
79% or 80% to 99% restenosis, we found that restenosis
rates were two to three times higher in patients who were
not patched compared with those in whom patching was
used. Overall, patching was used in 91% of the conventional
CEAs in our study cohort. However, as shown in Fig 2, the
rate of patching in conventional CEA increased from 87%
in 2003 to 96% in 2008 (P .0001). The increase in patch
use occurred concomitantly with the decline in restenosis,
especially 80% to 99% restenosis (Fig 3). Lastly, although
patch material varied over time, bovine pericardium was
most commonly used in each year, and its use increased
significantly during the study period, from 42% in 2003 to
82% in 2008 (P  .0001).
Third, the incidence of restenosis also varied by CEA
type. The incidence of 50% to 79% restenosis was higher in
patients undergoing eversion CEA (14%) compared with
conventional CEA (7%, P  .001). Similarly, 80% to 99%
restenosis rates were significantly higher in patients under-
going eversion CEA (6%) vs conventional CEA (1%, P 
.001).
Other univariate relationships between 80% to 100%
restenosis and patient variables are reported in Table I. Of
note, several variables that were significant in prior stud-
ies,17-21 such as smoking, statin use, antiplatelet therapy,
and gender, were not associated with higher or lower rates
of restenosis in our cohort.
Multivariable predictors of restenosis. To take into
account the interactions between the time-dependent
changes in process of care, as well as univariate associations,
we constructed a Cox proportional hazards model to pre-
arotid endarterectomy (CEA) after conventional CEA is
ars, representing Dacron patch material, refers to the
This amount was 1% in each year.for c
ray bdict the likelihood that 80% to 100% restenosis would
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able analysis indicated three risk factors were associated
with increased risk of 80% to 100% restenosis after conven-
tional CEA (Table III). The absence of patching (HR, 3.2;
95% CI, 1.5-7.0), contralateral internal carotid artery ste-
nosis 80% (HR, 4.1; 95% CI, 1.4-11.5), and dialysis
dependence (HR, 3.5; 95% CI, 1.2-9.8) were indepen-
dently associated with a higher risk of an 80% to 100%
restenosis. The effect of each of these risk factors in our
multivariable model was additive; for example, the inci-
dence of restenosis at 1 year was only 2% for patients with
no risk factors but was 15% for patients with three or more
risk factors (log-rank between categories of risk, P .001).
Our model, derived using our derivation data set from
2003 to 2007, performed well in our validation data set
(Appendix C, online only) and also demonstrated good
discrimination of risk between patients with and without
risk factors (Harrell C concordance statistic, 0.60).22,23
We similarly attempted to construct a procedure-
specific model for restenosis after eversion CEA. In univar-
iate analyses, within the group of patients undergoing
eversion CEA, we found that extremes of age (age 60 or
90 years), increasing degree of contralateral stenosis, and
lack of protamine use were all associated with higher risk of
3%
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R
es
te
no
si
s 
R
at
e
80-99% Restenosis
Fig 3. Comparison shows 80% to 99% restenosis rate
patching between 2003 and 2008.
Table III. Multivariate Cox proportional hazards model
predicting percentage of 80% to 100% restenosis after
conventional carotid endarterectomya
Variable HR (95% CI) P
Primary carotid closure
(no patch angioplasty) 3.2 (1.5-7.0) .003
Contralateral 80% internal
carotid artery stenosis 4.1 (1.4-11.5) .001
Dialysis 3.5 (1.2-9.8) .022
CI, Confidence interval; HR, hazard ratio.
aHarrell C-concordance statistic, 0.60.restenosis in univariate analyses (Table I). In Cox multiva-riable analysis, however, only age 50 to 59 was significant
(HR, 3.3; 95% CI, 1-4-7.9, P  .008).
DISCUSSION
Our analysis of restenosis rates after CEA showed that
clinically significant restenosis was uncommon within the
first year after surgery, and restenosis was not related to
other adverse outcomes such as stroke or death. Conven-
tional CEA with patch angioplasty was used more com-
monly over time in our region, whereas primary closure and
eversion CEA were used less often. These changes were
associated with a decline in the rates of restenosis over time.
In multivariable analysis of patients undergoing conven-
tional CEA, we identified lack of patch angioplasty, critical
contralateral stenosis, and dialysis dependence as risk fac-
tors for the development of restenosis.
Significant changes in processes of care with CEA oc-
curred in our region during the study period. First, sur-
geons across our region used patch angioplasty more com-
monly over time. Evidence from a variety of sources has
demonstrated that closure of the arteriotomy after CEA
should routinely involve the use of a patch.2,3,5-7,17,18,21 A
recent Cochrane Systematic Review studied 1127 patients
undergoing 1307 CEAs.24 Although the quality of these
studies was generally categorized as “poor” because of high
loss to follow-up, the authors found that patching was
associated with a decreased risk of stroke (OR, 0.39; P 
.007) and an even more dramatic decline in the risk of
restenosis at long-term follow-up (OR, 0.20; 95% CI,
0.13-0.29; P  .0001).2 Given the intent of our quality-
improvement group to monitor important processes of
care, we recorded the use of patch angioplasty as part of our
database and routinely reported this measure at our bian-
nual meetings. Accordingly, given the temporal changes in
patch angioplasty and restenosis rate, we believe that this
strategy was associated with a change in practice patterns
and better outcomes.
Why did practice patterns and outcomes change during
2%
1%
0%
6%
5%
4%
2006 2007 2008
p<0.001
p<0.001
Conventional
CEA without 
Patch
conventional carotid endarterectomy (CEA) withoutYear
 
andour study period? It is difficult to determine this directly.
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record our procedures and outcomes, and we meet twice
yearly to review our results. These meetings serve as an
opportunity for quality-improvement discussion and initi-
atives. One of the ongoing efforts of the group has been to
study the use of patching after CEA, and discussions were
held at some meetings to review the indications and tech-
niques surrounding this process of care. Although no spe-
cific quality-improvement project was conducted to in-
crease the use of patching, the act of studying and reporting
its use may have caused surgeons to implement this process
in their practices.25 This phenomenon, described as the
Hawthorne effect, has been implicated in many settings as a
potential explanation for improvement resulting from
changes in processes of care.26
In addition to patch angioplasty, another process of
care changed during the study period: eversion CEA was
used was less frequently. As with the use of patching,
feedback was given to surgeons regarding their results with
eversion CEA. Unlike patching, however, wherein clear
evidence exists to guide surgical decision making, the ad-
vantages and disadvantages of the technique of eversion
CEA are less well defined. Some studies have shown clear
benefit with eversion CEA. For example, in a randomized
trial of 86 patients who underwent conventional CEA with
patch angioplasty on one side and eversion CEA on the
other, the rate of restenosis was significantly higher at 2
years in patients undergoing conventional CEAwith patch-
ing (98% vs 87%, P .001).20 However, several large series
of eversion and conventional CEAs failed to demonstrate
any difference in restenosis rate between the two tech-
niques.17,27-29 Although this debate is likely to continue,
most vascular surgeons remain somewhat reassured none-
theless, as several large, recent series and trials have found
that restenosis rates remain quite low after both types of
endarterectomy.
Our study has several limitations. First, our model did
not identify certain risk factors that predicted restenosis
after CEA in prior studies. For example, we did not find
that female gender was associated with restenosis after
conventional CEA. In a smaller, single-surgeon series re-
ported in 2007, Crawford et al17 reported higher restenosis
rates in women as well as in patients with peripheral arterial
disease. Our model identified the severity of coexisting
vascular disease in the contralateral internal carotid artery as
a multivariable predictor of restenosis, but we did not find
a univariate or multivariable association with gender. This
may be secondary to the longer follow-up time in the
Crawford et al study (5 years vs 1 year), as well as differences
in our statistical modeling techniques (logistic models vs
Cox proportional hazards). Despite differences such as this,
our results largely agree with the findings of several other
series and randomized trials.17-21
Second, we only measured restenosis within the first
year after CEA. As many have described, restenosis after
CEA occurs in a bimodal distribution.4,17,30-33 Those pa-
tients who present with early restenosis are most likely to
have intimal hyperplasia as the cause of the recurrence,whereas restenosis that commonly occurs several years after
CEA is usually secondary to progression of atherosclerosis.
Thus, our model, based on 1-year outcomes, should not be
extrapolated to long-term restenosis rates or in arguments
toward limiting the need for reintervention in those pa-
tients who do experience restenosis.
Third, DU criteria for specific carotid stenosis percent-
ages were not uniform across centers but rather were de-
fined within each hospital, and factors such as the effect of
a contralateral stenosis or occlusion on velocity criteria
might vary across centers. Nonetheless, all of the vascular
laboratories in the VSGNE centers are certified by the
Intersocietal Commission for the Accreditation of Vascular
Laboratories, and the same criteria were used over time in
each center, so that the changes that we observed over time
should be valid, even though the rates might differ depend-
ing on the precise DU criteria used. Approximately 18% of
all patients did not have DU follow-up in our analysis.
However, this population was not different than our study
cohort in terms of risk factors for restenosis, and we have
little reason to suspect that these patients are systematically
more likely to experience restenosis.
Fourth, our study included almost exclusively white
patients, reflecting the demographics of our region, and
our lack of racial diversity may limit the overall generaliz-
ability of our findings. However, despite several large trials
and series that studied patients with a broader racial profile
than our cohort,7 there is little evidence to suggest that
racial differences contribute in a meaningful way toward
higher rates of restenosis after CEA.
Lastly, some might suggest that the improvement ob-
served in our region simply reflected changes in the propor-
tion of CEAs performed by specific surgeons, such that
surgeons with high restenosis rates performed fewer CEAs
over time. Our analysis indicates that this was not the case.
A small number of surgeons contributed nearly 20% of all
CEAs in our cohort, and these same surgeons contributed
almost 50% of all restenoses events. Each of these surgeons
was present in the VSGNE during the entire study period.
Each of these surgeons was more likely to use patching in
conventional CEA in the later years in our study, and each
surgeon had a lower restenosis rate as time ensued. There-
fore, although small sample sizes precluded accurate statis-
tical analysis of this outcome at the surgeon level, we find it
unlikely that surgeon “migration” in or out of the VSGNE
explains the differences found in our study.
CONCLUSIONS
In a large cohort of patients undergoing CEA, we
identified several risk factors associated with restenosis
within the first year, including lack of patch angioplasty
after conventional CEA. Use of patch angioplasty after
conventional CEA increased over time in our region, which
we postulate was related to our benchmarked reporting of
this preidentified quality measure. We believe that this
finding emphasizes the potential beneficial role of regional
quality-improvement groups in vascular surgery.
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Dr William D. Jordan (Birmingham, Ala). Dr Goodney has
reported a 5-year series of carotid endarterectomy from the Vascu-
lar Study Group of New England (VSGNE), and analyzed theperformed 4465 operations for primary carotid stenosis, or 13
operations per surgeon per year—not an enormous number. How-
ever, 175 or 3.5% died and were not available for the surveillance
study. Additionally, nearly 1000 did not have 1-year data, leaving
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Volume 52, Number 4 Goodney et al 90577% for analysis. Finally, considering only 1.7% of these had critical
recurrent stenosis, likely asymptomatic, and only one-quarter re-
quired reintervention within that period, that is a paltry number
considering this large series. Now, considering the increased pres-
sure for “value-based medicine” (aka, a Washington bureaucrat
telling us when to order a study or when to do an operation), is it
really worthwhile to intensely survey these patients? Can we show
a value in postoperative scanning when the need for reintervention
is so low?
Next, you andDr Cronenwett should be congratulated for the
efforts you have undertaken to keep this study group chugging and
producing continued clinical reports about various aspects of vas-
cular disease. You have nicely demonstrated that, despite my
frustrations in training young pups to be vascular surgeons, that
you can teach an old dog new tricks. You have shown an increasing
utilization of patching during endarterectomy during the years of
the report. I presume this change is related to the feedback
provided to your surgeons during the semiannual update meet-
ings.
Can you also assure me of some duplex ultrasound consisten-
cies across the 67 surgeons? You noted that contralateral stenosis
80% was associated with a higher rate of recurrent stenosis on the
operated side. This may reflect a difference in ultrasound criteria at
each site. How do we know that the ultrasound criteria for reste-
nosis are consistent and validated at each of these sites?
Finally, the primary point of your paper shows that the reste-
nosis rate is higher without patching and is also likely related to use
of the eversion technique (even though the numbers were too
small in this subgroup to make statistical statement) at 6% at 1 year
compared to 1% in the conventional (and most often patched)
group. This phenomenon needs further explanation, particularly
considering that your neighbors in Albany, NY, promote the
eversion technique as the best way to perform the procedure.
While I may need a geography lesson, Albany is close to your own
New England area, and we Southern folk may need more explana-
tion about why those trainees from Albany are not able to repro-duce the results of the mother ship. Are these surgeons in your
group just not performing the eversion technique in the correct
way to remove all the plaque and media to avoid the problem with
recurrent stenosis? Help us here.
Again, thank you for sending the manuscript to me well ahead
of the deadline for my review. You are to be congratulated for the
continued academic efforts to improve the quality of vascular care
for your region and around the United States.
Dr Goodney. Thank you very much, Dr Jordan. In regard to
your first question: should we surveil? The short answer is, I don’t
know. However, your question gave me a good idea about what
might be some subsequent research work. One could conceive that
you could utilize the restenosis rate fromourwork here as an input for
a decision analysis model and subsequently try to perform cost-
effective analysis to determine the cost-effectiveness of screening.
This is something we will work on in the future, certainly.
Secondly, about duplex criteria, our work is not a randomized
trial, of course, and we did not have a core lab. However, all the
vascular surgery practices that make up the VSGNE have ICAVL
(Intersocietal Commission for the Accreditation of Vascular Lab-
oratories) certified labs. While I can’t tell you offhand with cer-
tainty that everybody has exactly the same criteria for 80% to 99%,
they all indeed have been ICAVL certified.
The last question, about whether or not some surgeons are
doing eversions the right way, I have only been in practice for
about a year now, but even I know better than to point fingers
about how someone performs their carotids. I think that is an
interesting question. We have a relatively small sample, as I have
mentioned, of eversion endarterectomy. I think one of the impor-
tant findings, however, is that the surgeons that comprised the
procedures outcomes in this analysis were stable over time. It
wasn’t that the high restenosis surgeons left town, and that some-
body else took over. These changes represent essentially the same
cohort of surgeons, so we believe that the surgeons really did
change their practice patterns over time.
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October 2010905.e1 Goodney et alAPPENDIX A (online only). Hospitals contributing
data in the Vascular Study Group of Northern New
England, carotid cohort (2003-2008)
Catholic Medical Center, Manchester, NH
Central Maine Medical Center, Lewiston, Me
Concord Hospital, Concord, NH
Cottage Hospital, Woodsville, NHEastern Maine Medical Center, Bangor, Me
Fletcher Allen Health Care, Burlington, Vt
Lakes Regional General Hospital, Laconia, NH
Maine Medical Center, Portland, Me
Mercy Hospital, Portland, Me
University of Massachusetts Memorial Medical Center,Dartmouth-Hitchcock Medical Center, Lebanon, NH Worcester, Mass
APPENDIX B (online only). Patient characteristics without a significant univariate relationship to 80% to 100%
restenosis rate in univariate analysis
Variable
Conventional endarterectomy (n  2611) Eversion endarterectomy (n  370)
% of
total
80%-100% restenosis rate, %
P
% of
total
80%-100% restenosis rate, %
P
If variable
absent
If variable
present
If variable
absent
If variable
present
Patient characteristics
Symptom status
Ipsilateral symptoms
Cortical (TIA or stroke) 36 1.6 1.6 .927 35 6.2 10.2 .155
Ocular 13 1.7 1.1 .625 14 6.1 16.3 .029
Vertebrobasilar 2 1.5 4.9 .218 2 7.8 0.0 .746
Pre-op medications
Antiplatelet agent
Aspirin only 87 2.2 1.5 .323 76 6.4 8.0 .606
Clopidogrel 17 1.7 1.3 .554 7 7.7 6.9 .88
Both agents 89 2.5 1.5 .226 78 6.9 7.8 .775
Statin 71 1.6 1.6 .704 67 5.3 8.8 .23
Prior radiotherapy 1 1.5 5.4 .05 1 7 33 .08
Operative characteristics
General anesthesia 89 0.0 1.8 .06 96 8.3 2.4 .345
Routine shunting 50 2.0 1.3 .125 6 7.6 8.3 .891
Dextran use 5 1.6 1.5 .943 7 8.2 0.0 .108
Completion study 31 1.8 1.0 .203 64 8.4 7.2 .661
CABG, Coronary artery bypass grafting; PCI, percutaneous coronary intervention; TIA, transient ischemic attack.
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